Intention to treat analysis

Jump to navigation Jump to search

WikiDoc Resources for Intention to treat analysis

Articles

Most recent articles on Intention to treat analysis

Most cited articles on Intention to treat analysis

Review articles on Intention to treat analysis

Articles on Intention to treat analysis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Intention to treat analysis

Images of Intention to treat analysis

Photos of Intention to treat analysis

Podcasts & MP3s on Intention to treat analysis

Videos on Intention to treat analysis

Evidence Based Medicine

Cochrane Collaboration on Intention to treat analysis

Bandolier on Intention to treat analysis

TRIP on Intention to treat analysis

Clinical Trials

Ongoing Trials on Intention to treat analysis at Clinical Trials.gov

Trial results on Intention to treat analysis

Clinical Trials on Intention to treat analysis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Intention to treat analysis

NICE Guidance on Intention to treat analysis

NHS PRODIGY Guidance

FDA on Intention to treat analysis

CDC on Intention to treat analysis

Books

Books on Intention to treat analysis

News

Intention to treat analysis in the news

Be alerted to news on Intention to treat analysis

News trends on Intention to treat analysis

Commentary

Blogs on Intention to treat analysis

Definitions

Definitions of Intention to treat analysis

Patient Resources / Community

Patient resources on Intention to treat analysis

Discussion groups on Intention to treat analysis

Patient Handouts on Intention to treat analysis

Directions to Hospitals Treating Intention to treat analysis

Risk calculators and risk factors for Intention to treat analysis

Healthcare Provider Resources

Symptoms of Intention to treat analysis

Causes & Risk Factors for Intention to treat analysis

Diagnostic studies for Intention to treat analysis

Treatment of Intention to treat analysis

Continuing Medical Education (CME)

CME Programs on Intention to treat analysis

International

Intention to treat analysis en Espanol

Intention to treat analysis en Francais

Business

Intention to treat analysis in the Marketplace

Patents on Intention to treat analysis

Experimental / Informatics

List of terms related to Intention to treat analysis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

In epidemiology, an intention to treat (ITT) analysis is an analysis based on the initial treatment intent, not on the treatment eventually administered. The ITT analysis includes all patients randomized to a therapy irrespective of protocol deviations, discontinuation of study drug, drug administration errors, cross-over to another strategy, or withdrawal from the study by the subject. For example, in a trial comparing medical therapy to angioplasty for coronary artery disease, those patients who were initially randomized to medical therapy but who crossed-over to receive an angioplasty instead due to a failure of medical therapy are analyzed as part of the medical therapy cohort. This form of analysis differs significantly from a per protocol (PP) analysis in which only those subjects are included who actually received study drug as specified in the study protocol.

Philosophy of an ITT Analysis

In a way, an ITT analysis tests a strategy of administering the therapy, rather than the therapy itself. It is based on the assumption that, as in real life, sometimes patients do not all receive optimal treatment, even though that was the initial intention. For the purposes of analysis, the reasons why the patient did not receive the treatment are ignored.

Rationale

Randomization of subjects at the beginning of a trial assures that any imbalances in risk factors, demographics and confounders will be minimized. An ITT analysis preserves that initial randomization, and avoids the effects of crossover and drop-out, which may break the randomization to the treatment groups in a study. Patients who discontinue study drug therapy may do so due to side effects or a perceived lack of effectiveness. As a result, the remaining population is enriched with those patients who could tolerate the drug or perhaps had their symptoms improved on the treatment. Simply put, this remaining "per protocol" cohort harvests out those subjects who were "success stories", and eliminates those patients who failed. An ITT analysis is a more conservative form of analysis because it incorporates patients who failed therapy, could not take therap and who may have crossed over to other therapies. A per protocol analysis of those patients who successfully followed the protocol may overestimate the efficacy of a treatment.

In contrast, efficacy subset analysis selects the subset of the patients who received the treatment of interest--regardless of initial randomization--and who have not dropped out for any reason. This approach can :

  • introduce biases to the statistical analysis
  • inflate the type I error; this effect is greater the larger the trial[1].

Full application of intention to treat can only be performed where there is complete outcome data for all randomised subjects.

Although intention to treat is widely cited in published trials, it is often incorrectly described and its application may be flawed.

References

  1. Lachin JM (2000). "Statistical Considerations in the Intent-to-Treat Principle". Statistics in Medicine. 21 (3): 167–189. PMID 10822117. Unknown parameter |month= ignored (help)

See also

External links

Template:SIB

de:Intention-to-treat


Template:WikiDoc Sources